3 May 2019 · A UKMi Product Safety assessment on trastuzumab products (including the biosimilars) which describes the in-use medication safety considerations resultant from the product’s presentation or other…
23 September 2020 · Antineoplastic agents, whether used as monotherapy or in combination with other antineoplastics, are contra-indicated in breastfeeding (unless indicated below) because of their effects on dividing…